Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China
· Delayed Price · Currency is CNY 8.93
-0.11 (-1.22%)
At close: Mar 9, 2026
SHA:600867 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 1,226 | -42.72 | 1,168 | 1,582 | 1,308 | 929.92 | Upgrade
|
| Depreciation & Amortization | 188.2 | 188.2 | 185.87 | 151.17 | 143.65 | 154.54 | Upgrade
|
| Other Amortization | 0.81 | 0.81 | - | - | - | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -15.13 | -15.13 | -0 | -0.19 | -7.71 | -0.41 | Upgrade
|
| Asset Writedown & Restructuring Costs | 335.78 | 335.78 | 10.13 | 2.04 | 23.04 | 62.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | -123.29 | -123.29 | -92.45 | -930.32 | -296.88 | -39.54 | Upgrade
|
| Provision & Write-off of Bad Debts | -15.59 | -15.59 | 20.12 | -7.41 | 2.26 | 0.9 | Upgrade
|
| Other Operating Activities | -1,062 | 51.07 | 11.93 | -6.65 | 10.31 | 1.64 | Upgrade
|
| Change in Accounts Receivable | 319.11 | 319.11 | -430.93 | 140.57 | -88.27 | 2.33 | Upgrade
|
| Change in Inventory | -48.51 | -48.51 | -55.53 | -124.65 | -3.41 | 97.28 | Upgrade
|
| Change in Accounts Payable | -90.21 | -90.21 | 36.99 | 52.93 | 93.84 | -17.13 | Upgrade
|
| Operating Cash Flow | 614.83 | 459.74 | 861.52 | 863.09 | 1,180 | 1,192 | Upgrade
|
| Operating Cash Flow Growth | 0.21% | -46.64% | -0.18% | -26.88% | -1.00% | 3.48% | Upgrade
|
| Capital Expenditures | -400.94 | -568.73 | -348.13 | -492.88 | -600.75 | -479.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.37 | 66.36 | 0.42 | - | 20.37 | 1.28 | Upgrade
|
| Cash Acquisitions | 3.75 | 0.15 | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | - | -22.13 | Upgrade
|
| Investment in Securities | 1,148 | -100 | 2.5 | 817.06 | 544.82 | -150 | Upgrade
|
| Other Investing Activities | 40.19 | 33.29 | 23.22 | 19.82 | 23.79 | 33.84 | Upgrade
|
| Investing Cash Flow | 791.06 | -568.93 | -321.99 | 343.99 | -11.76 | -616.61 | Upgrade
|
| Long-Term Debt Issued | - | 840.25 | 314.03 | - | - | 275 | Upgrade
|
| Total Debt Issued | 730.5 | 840.25 | 314.03 | - | - | 275 | Upgrade
|
| Long-Term Debt Repaid | - | -447.03 | -40 | - | - | -400 | Upgrade
|
| Total Debt Repaid | -595.47 | -447.03 | -40 | - | - | -400 | Upgrade
|
| Net Debt Issued (Repaid) | 135.03 | 393.22 | 274.03 | - | - | -125 | Upgrade
|
| Issuance of Common Stock | 15.97 | 7.25 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | -300.28 | -300.28 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -495.77 | -495.78 | -496.25 | -1,096 | -425.04 | -403.58 | Upgrade
|
| Other Financing Activities | 406.19 | -13.17 | -1.74 | -188.28 | -270.56 | 47.79 | Upgrade
|
| Financing Cash Flow | -238.86 | -408.76 | -223.95 | -1,284 | -695.6 | -480.79 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0.34 | 0.57 | 0 | -0 | -0 | Upgrade
|
| Net Cash Flow | 1,167 | -517.61 | 316.14 | -76.98 | 473.01 | 94.9 | Upgrade
|
| Free Cash Flow | 213.89 | -108.99 | 513.4 | 370.21 | 579.62 | 712.69 | Upgrade
|
| Free Cash Flow Growth | 187.05% | - | 38.68% | -36.13% | -18.67% | -17.04% | Upgrade
|
| Free Cash Flow Margin | 7.80% | -5.42% | 16.69% | 13.32% | 17.74% | 24.64% | Upgrade
|
| Free Cash Flow Per Share | 0.11 | -0.05 | 0.26 | 0.18 | 0.28 | 0.35 | Upgrade
|
| Cash Interest Paid | 10.01 | 10.01 | 1.66 | - | - | 10.17 | Upgrade
|
| Cash Income Tax Paid | 374.44 | 166.17 | 219.83 | 284.18 | 217.64 | 279.58 | Upgrade
|
| Levered Free Cash Flow | 343.03 | -151.63 | 373.08 | 187.64 | 347.72 | 593.12 | Upgrade
|
| Unlevered Free Cash Flow | 356.66 | -142.64 | 376.31 | 187.81 | 347.72 | 599.48 | Upgrade
|
| Change in Working Capital | 80.61 | 80.61 | -441.92 | 72.56 | -2.56 | 82.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.